Shopping Cart
Remove All
Your shopping cart is currently empty
DBI-2, an AMPK activator targeting mitochondrial complex I, disrupts the OXPHOS process and reduces ATP production in mitochondria. Additionally, DBI-2 inhibits the proliferation of colorectal cancer (CRC) cells.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 4-6 weeks | 4-6 weeks | |
| 50 mg | $1,980 | 4-6 weeks | 4-6 weeks | |
| 100 mg | $2,500 | 4-6 weeks | 4-6 weeks |
| Description | DBI-2, an AMPK activator targeting mitochondrial complex I, disrupts the OXPHOS process and reduces ATP production in mitochondria. Additionally, DBI-2 inhibits the proliferation of colorectal cancer (CRC) cells. |
| In vitro | DBI-2 inhibits the proliferation of LS174T and HCT116 cells with IC 50 values of 1.14 μM and 0.53 μM, respectively [1]. At a concentration of 3 μM for 24 hours, DBI-2 induces growth inhibition by activating AMPK and suppressing the mTOR and Wnt pathways [1]. |
| In vivo | DBI-2 (40 mg/kg; intraperitoneal injection; for 12 days) effectively inhibits tumor growth in a colorectal cancer (CRC) xenograft mouse model [1]. Animal Model: RAG1 −/− γc − mice injected with S174T cells [1] Dosage: 40 mg/kg Administration: Intraperitoneal administration; for 12 days Result: Suppressed tumor growth. |
| Molecular Weight | 473.40 |
| Formula | C24H29BrN2O3 |
| Cas No. | 2939087-00-8 |
| Smiles | O=C1C(=COC2=CC(OCCCCN(C)CCN(C)C)=CC=C21)C=3C=CC(Br)=CC3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.